Fifth Metatarsal Orthopedic Outcome Trial (FOOT)

February 28, 2023 updated by: Maarten Cornelissen, Isala

Treatment of Fifth Metatarsal Shaft Fractures: A Randomized Controlled Trial

Fractures of the shaft, distal to zone three, of the fifth metatarsal often occur after foot distortion. There is very little evidence available regarding the optimal treatment. Currently the most common treatment is prolonged cast immobilization. Operative treatment has been reported as an alternative and could promote early recovery. No comparative study has been published regarding optimal treatment

Study Overview

Detailed Description

Objective: The main objective is to determine experienced pain, as measured by NRS-11 score, 3 months after intervention and compare this between the intervention and control group. Secondary objectives are functional outcome as measured by AOFAS Lesser Toe Scale, FAAM score, progress of NRS-11 score through time and PROMIS Mobility/pain interference. Furthermore, quality and duration of fracture healing will be compared between groups. The impact on daily life will be compared as measured by duration of return to work and normal footwear.

Study design: Randomised controlled clinical intervention trial

Study population: Humans with an acute shaft fracture of the fifth metatarsal bone, 18 years or older.

Study Type

Interventional

Enrollment (Anticipated)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Roelina Munnik-Hagewoud, PhD
  • Phone Number: 0886245375
  • Email: r.munnik@isala.nl

Study Locations

      • Groningen, Netherlands, 9728NT
        • Recruiting
        • Martini Ziekenhuis
        • Contact:
    • Gelderland
      • Arnhem, Gelderland, Netherlands, 6815AD
    • Overijssel
      • Zwolle, Overijssel, Netherlands, 8025AB

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years or older at the time of study entry
  • Informed consent
  • Competent to participate in follow up and fill out questionnaires
  • Dislocated (1mm or more on plain radiography) fracture of the shaft, distal from zone 3, of the fifth metatarsal according to the Orthopedic Trauma Association (OTA) classification 87.5.3 A-C

Exclusion Criteria:

  • Open fracture
  • Proximal fifth metatarsal fracture, Jones fracture
  • Clinically significant or symptomatic vascular or neurologic pathology on the ipsilateral leg
  • Former surgery or history of development disorder of the contralateral fifth metatarsal
  • Multiple fractured metatarsals in the affected foot
  • Medical history of Rheumatoid Arthritis
  • Unable to undergo surgical procedure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
The intervention group is offered surgical treatment of the shaft fracture of the fifth metatarsal bone with ORIF. Depending on the type of shaft fracture this will be either lag screw fixation or plate fixation. After surgery a period of cast immobilisation with gradual increase of weight bearing will commence
Surgical intervention by lag screw or plate fixation
Active Comparator: Control
The control group (conservative treatment), will receive a period of cast immobilisation, with a gradual increase in weight bearing by protocol.
Cast immobilsation for a total of 6 weeks with gradual increase in weight bearing after 2 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numerical rating scale-11 score for pain 3 months
Time Frame: 3 months after intervention
Numerical rating scale, score ranging from 0-10 where 10 is a worse outcome
3 months after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numerical rating scale-11 score for pain through time
Time Frame: 0-12 months after intervention
Numerical Rating Scale-11 score progression through different time points (6 weeks, 3,6 and 12 months after intervention. Score ranging from 0-10. A Higher score is a worse outcome
0-12 months after intervention
American Orthopedic Foot &Ankle Society Lesser Toe Scale
Time Frame: 3 months after intervention
American Orthopedic Foot &Ankle Society Lesser Toe Scale between groups, functional outcome measure for patients with lesser toe (i.e. excluding hallux) and midfoot pathology. Score ranging from 0-100. A Higher score is a better outcome
3 months after intervention
Foot and Ankle Ability Measure
Time Frame: 6 weeks, 3,6 and 12 months after intervention
Foot and Ankle Ability Measure, a score with two subscales: Activities of Daily Living (ADL) and sports. The questions concern function of the foot and ankle. progression through different time points (6 weeks, 3,6 and 12 months after intervention). Score ranging from 0-120. A higher score is a better outcome
6 weeks, 3,6 and 12 months after intervention
Patient Reported Outcome Measure Information System - Mobility
Time Frame: 6 weeks, 3,6 and 12 months after intervention
patient reported outcome measures by using Computer Adaptive Testing. Results in a normalized score ranging from 0-100 where an average human being will score 50. Higher score is a better outcome.
6 weeks, 3,6 and 12 months after intervention
Patient Reported Outcome Measure Information System - Pain Interference
Time Frame: 6 weeks, 3,6 and 12 months after intervention
Patient reported outcome measures by using Computer Adaptive Testing. Results in a normalized score ranging from 0-100 where an average human being will score 50. Higher score is a better outcome.
6 weeks, 3,6 and 12 months after intervention
Return to work
Time Frame: 0-12 months
Duration of resumption of work
0-12 months
Return to normal footwear
Time Frame: 0-12 months
Duration of return to normal footwear
0-12 months
Malunion
Time Frame: 6 weeks after intervention
Length of fractured fifth metatarsal as compared to ipsilateral fifth metatarsal
6 weeks after intervention
Non union
Time Frame: 0-6 months
Determined by plain X-ray on 6 weeks, 3 months and 6 months, categorical outcome
0-6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Rutger Zuurmond, MD, PhD, Isala

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2022

Primary Completion (Anticipated)

June 1, 2024

Study Completion (Anticipated)

December 1, 2024

Study Registration Dates

First Submitted

July 4, 2022

First Submitted That Met QC Criteria

July 4, 2022

First Posted (Actual)

July 8, 2022

Study Record Updates

Last Update Posted (Actual)

March 2, 2023

Last Update Submitted That Met QC Criteria

February 28, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 80748.075.22

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metatarsal Fracture

Clinical Trials on Open Reduction Internal Fixation

Subscribe